Cargando…
Targeting VIP and PACAP receptor signalling: new therapeutic strategies in multiple sclerosis
MS (multiple sclerosis) is a chronic autoimmune and neurodegenerative pathology of the CNS (central nervous system) affecting approx. 2.5 million people worldwide. Current and emerging DMDs (disease-modifying drugs) predominantly target the immune system. These therapeutic agents slow progression an...
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
American Society for Neurochemistry
2011
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3189630/ https://www.ncbi.nlm.nih.gov/pubmed/21895607 http://dx.doi.org/10.1042/AN20110024 |